1. New Zealand
  2. All 3M Products
  3. Medical
  4. Bandages & Dressings
  5. Compression Therapy Bandages
  6. 3M™ Coban™ 2 Layer Compression System 2094N, 8/CTN
This product is not available for purchase by the general public.
This product is now sponsored by KCI New Zealand Unlimited, wholly owned subsidiaries of Solventum.

3M™ Coban™ 2 Layer Compression System 2094N, 8/CTN

  • 3M ID 70200789280

Provides sustained therapeutic compression for up to 7 days.

Clinically proven to significantly reduce slippage and improve patient`s daily living activities.

Easy and fast to apply.

View more details

Details

Highlights
  • Provides sustained therapeutic compression for up to 7 days
  • Clinically proven to significantly reduce slippage and improve patient`s daily living activities
  • Easy and fast to apply
  • The compression layer is designed to be applied at full stretch, reducing application variability for consistent, reliable compression at every application
  • The thin, lightweight, breathable sleeve allows patients to wear their own shoes, so they can return to their regular daily activities
  • Latex-free
  • For the treatment of oedema associated with venous leg ulcers and associated conditions. Suitable for patients with an ABPI 0.8 and above

3M™ Coban™ 2 Layer Compression System 2094N

Specifications

Boxes per Case

8.0

Brands

Coban™

Catalog Number

2094N

Comfort Layer Length (Metric)

2.7 Metre

Comfort Layer Width (Metric)

10 cm

Condition

Wound Care

Features

With Stocking

Hypoallergenic

Yes

Inner Packs per Case

8 Cartons per Case

Latex

No

Product Type

Compression Wrap

Units per Inner Pack

1 per Carton

Units per Pack

1

Wound Care Condition Type

Venous Leg Ulcer

Overall Length (Metric)

1.189 Metre

Overall Width (Metric)

10 cm

1.      Moffatt C et al (2008) ‘A randomised controlled 8-week crossover clinical evaluation of the 3M™ Coban™ 2 Layer Compression System versus Profore™ to evaluate the product performance in patients with venous leg ulcers’. International Wound Journal; 5:267-279.